The spring season on Broadway has already yielded a bumper crop of B.O. earners, with four recent openers breaking the $1 million mark and landing in the Top 10 last week.
One of those powerhouses, Tom Hanks starrer “Lucky Guy” ($1,384,178), won’t be around for long: The production is skedded to close once Hanks exits July 3. But the three tuners on the list – “Motown” ($1,213,611), “Kinky Boots” ($1,112,163) and “Matilda” ($1,107,815) – are each making a promising start on what could be a potentially long run, with Tuesday’s Tony noms and June 9 awards coming up to add fuel to the fire should any of the titles prove to be kudo faves.
Meanwhile, another spring outing, concert-bio hybrid “The Rascals: Once Upon a Dream” ($776,214 for five perfs), continues to impress, joining a string of concert outings this season (“Manilow on Broadway,” “Frankie Valli and the Four Seasons on Broadway”) that have logged healthy numbers from a restricted number of perfs. “Macbeth” ($456,931 for six) also did well for a solo show that plays less than the traditional eight perfs per week.
Otherwise it was up a little here, down a little there, with overall Broadway sales of $24,586,124 for 31 shows on the boards remaining essentially on par with the prior frame’s cume. Attendance dipped by about 10,000 to 250,970.
In the run-up to the April 25 Tony eligibility cutoff, four shows opened last week but, unusually, three of them managed to uptick despite the comp-heavy sesh, perhaps benefiting from press attention. “Pippin” ($713,712), “The Trip to Bountiful” ($491,501) and “The Testament of Mary” ($216,533) each climbed a bit. Bette Midler starrer “I’ll Eat You Last” ($646,102 for seven) was down somewhat, thanks in part to its comped and very starry opening night perf, but don’t feel too bad: The well-reviewed production, in a house small enough to keep ticket demand high, looks likely to keep its sales momentum robust throughout its limited engagement.
Among other plays on the boards, the recently opened Nathan Lane topliner “The Nance” ($445,409) and Alec Baldwin starrer “Orphans” ($444,469) posted decent if unspectacular numbers.
Like the rest of the shows now running, the commercial revival of “Orphans” is waiting to see just how much any potential Tony attention will affect sales.